Quirk Gerald E 4
4 · Syros Pharmaceuticals, Inc. · Filed Feb 14, 2019
Insider Transaction Report
Form 4
Quirk Gerald E
Chief Legal Officer
Transactions
- Award
Common Stock
2019-02-12+87,000→ 87,000 total - Award
Stock Option (right to buy)
2019-02-12+75,000→ 75,000 totalExercise: $6.71Exp: 2029-02-11→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]The reporting person was granted restricted stock units, with each unit representing the right to receive one share of the issuer's common stock. These restricted stock units will vest in full on March 31, 2022.
- [F2]This option becomes exercisable as to 25% of the shares underlying the award on February 29, 2020, with the remainder vesting in equal monthly installments of 2.0833% of the shares underlying the award at the end of each successive month thereafter.